Urology Times presents Case-Based Peer Perspectives. In each video, expert physicians provide insight on managing urology-based patient cases that highlight the use of novel agents in clinical practice.
August 9th 2022
Jason Hafron, MD, presents the profile of a 66-year-old man with metastatic castration-sensitive prostate cancer, details the available treatment regimens, and discusses clinical trial data on the use of androgen deprivation therapy combined with a treatment-intensifying agent.
July 19th 2022
Gordon A. Brown, DO, presents the case of a man with prostate cancer, reviews available treatment options, and discusses data on combination androgen deprivation therapy/apalutamide in patients with metastatic castration-sensitive prostate cancer.
May 23rd 2022
Neal Shore, MD, presents the case of a 64-year-old man with metastatic prostate cancer, reviews the potential treatment options, including PARP inhibitors, and highlights the importance of genetic testing when selecting treatment regimens.
April 21st 2022
Judd W. Moul, MD, FACS, provides insight on screening and diagnosis of prostate cancer, and comments on the use of biomarker tests to aid in risk stratification, management, and treatment.